Does BEVACIZUMAB Cause Hepatic function abnormal? 769 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 769 reports of Hepatic function abnormal have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 1.0% of all adverse event reports for BEVACIZUMAB.
769
Reports of Hepatic function abnormal with BEVACIZUMAB
1.0%
of all BEVACIZUMAB reports
137
Deaths
268
Hospitalizations
How Dangerous Is Hepatic function abnormal From BEVACIZUMAB?
Of the 769 reports, 137 (17.8%) resulted in death, 268 (34.9%) required hospitalization, and 26 (3.4%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB. However, 769 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)
CARBOPLATIN (498)
Which BEVACIZUMAB Alternatives Have Lower Hepatic function abnormal Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ